BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16237709)

  • 1. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease.
    Ragni MV; Eghtesad B; Schlesinger KW; Dvorchik I; Fung JJ
    Liver Transpl; 2005 Nov; 11(11):1425-30. PubMed ID: 16237709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of human immunodeficiency virus-infected liver transplant recipients.
    Ragni MV; Belle SH; Im K; Neff G; Roland M; Stock P; Heaton N; Humar A; Fung JF
    J Infect Dis; 2003 Nov; 188(10):1412-20. PubMed ID: 14624365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort.
    Vogel M; Voigt E; Schäfer N; Goldmann G; Schwarz N; Kalff JC; Sauerbruch T; Wolff M; Rockstroh JK; Spengler U
    Liver Transpl; 2005 Dec; 11(12):1515-21. PubMed ID: 16315295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD.
    Stock PG
    Liver Transpl; 2005 Nov; 11(11):1315-7. PubMed ID: 16237693
    [No Abstract]   [Full Text] [Related]  

  • 8. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD and prediction of post-liver transplantation survival.
    Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.
    Durand F; Belghiti J; Troisi R; Boillot O; Gadano A; Francoz C; de Hemptinne B; Mallet A; Valla D; Golmard JL
    Liver Transpl; 2006 Feb; 12(2):231-9. PubMed ID: 16447208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients.
    Cowling T; Jennings LW; Goldstein RM; Sanchez EQ; Chinnakotla S; Klintmalm GB; Levy MF
    Ann Surg; 2004 Jan; 239(1):93-8. PubMed ID: 14685106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater travel time to a liver transplant center does not adversely affect clinical outcomes.
    Firozvi AA; Lee CH; Hayashi PH
    Liver Transpl; 2008 Jan; 14(1):18-24. PubMed ID: 18161800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.